%A XU Hui-Ru, FENG Hui-Jing, ZHANG Jun-Ping %T Biological therapy of ovarian cancer %0 Journal Article %D 2013 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2013.11.018 %P 861-864 %V 40 %N 11 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9258.shtml} %8 2013-11-08 %X In recent years, the biological therapy of ovarian cancer has made great progress. Immunotherapy including tumor vaccine and adoptive immunity cell therapy can improve immune recognition capability, while the applications of molecular targeted drugs such as monoclonal antibodies and tyrosine kinase inhibitors for different target spots during the tumor cells growth progresses achieve significant clinical benefit, as well as hormone replacement therapy and Chinese medicine treatment improve the life quality of patients with ovarian cancer to a certain degree.